Na+, K+-ATPase activity in the brain of the rats with kainic acid-induced seizures: Influence of lamotrigine

Psychiatria Danubina

Volumn 20, Issue 3, 2008, Pages 269-276

  Vitezić, Dinko ^a,b   Pelčić, Jasenka Mršić ^a   Župan, Gordana ^a   Vitezić, Miomira ^c   Ljubičić, Dulijano ^a,b   Simonić, Ante ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

^c Clinic for Orthopedic Surgery   (Croatia)

Author keywords

Cortex; Hippocampus; K+ ATPase activity; Kainic acid; Lamotrigine; Na+

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); KAINIC ACID; LAMOTRIGINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; RAT; SEIZURE; TEMPORAL CORTEX;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; KAINIC ACID; RATS; RATS, WISTAR; SEIZURES; SODIUM CHANNELS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRIAZINES;

EID: 54349086284     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Anderson WR, Franck JE, Stahl WL, Maki AA: Na, K-ATPase is decreased in hippocampus of kainate-lesioned rats. Epilepsy Res, 1994; 17: 221-231.
2. Ben-Ari Y: Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 1985; 14: 375-403.
3. Brines ML, Dare AO, de Lanerolle NC: The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus. Neurosci Lett, 1995; 191(3): 145-148.
4. Casanovas A, Ribera J, Hukkanen M, Riveros-Moreno V, Esquerda JE: Prevention by lamotrigine, MK-801 and N-nitro-L-arginine methyl ester of motoneuron cell death after neonatal axotomy. Neuroscience, 1996; 71(2): 313-325.
5. Chastain JE Jr, Samson F, Nelson SR, Pazdernik TL: Kainic acid-induced seizures: changes in brain extracellular ions as assessed by intracranial microdialysis. Life Sci, 1989; 45(9): 811-817.
6. Cheung H, Kamp D, Harris E: An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res, 1992; 13: 107-112.
7. Cowan CM, Cavalheiro EA: Epilepsy and membrane Na+K+ATPase: changes in activity using an experimental model of epilepsy. Acta Physiol Lat Am, 1980; 30(4): 253-258.
8. + pump. Adv Neurol, 1980; 27: 85-126.
9. + ATPase activity in the rat hippocampus: a study in the pilocarpine model of epilepsy. Neurochem Int, 1996; 28(5-6): 497-500.
10. Fisher RS: Animal models of the epilepsies. Brain Res Rev, 1989; 14: 245-278.
11. + pump in epilepsy. Ann Neurol, 1984; 16 (Suppl): 128-134.
12. Grisar T: Neuron-glia relationships in human and experimental epilepsy: a biochemical point of view. Adv Neurol, 1986; 44: 1045-1073.
13. +)-ATPase to focal epilepsy: a briefreview. Epilepsy Res, 1992; 12(2): 141-149.
14. +)-ATPase in epilepsy. A biochemical study in animals and humans. Acta Neurol Belg, 1988; 88: 257-280.
15. 14C-2-deoxyglucose method. Brain Res Rev, 1995; 20: 1-23.
16. + -ATPase. J Neurochem, 1994; 63: 2172-2178.
17. Lees GJ: Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res Rev, 1991; 16: 283-300.
18. Maj R, Fariello RG, Ukmar G, Varasi M, Pevarello P, McArthur RA, Salvati P: PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the fat. Eur J Pharmacol, 1998; 359 (1): 27-32.
19. McGeer EG, Zhu SG: Lamotrigine protects against kainate but not ibotenate lesions in fat striatum. Neurosci Lett, 1990; 112: 348-351.
20. Messenheimer JA: Lamotrigine. Epilepsia, 1995; 36 (Suppl.2): 87-94.
21. Nagy AK, Houser CR, Delgado-Escueta AV: Synaptosomal ATPase activities in temporal cortex and hippocampal formation of humans with focal epilepsy. Brain Res, 1990; 529: 192-201.
22. Nicklas WJ, Krespan B, Berl S: Effect of kainate on ATP levels and glutamate metabolism in cerebellar slices. Europ J Pharmacol, 1980; 62: 209-213.
23. Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D: Neuro-protection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol, 2008; 11: 321-329.
24. +-ATPase activity and phenytoin concentrations. Arch Neurol, 1975; 32: 549-554.
25. +-ATPase in serially excised segments of epileptic monkey cortex. Epilepsia, 1981; 22: 123-127.
26. Reime Kinjo E, Arida RM, Mara de Oliveira D, da Silva Fernandes MJ: The Na+/K+ATPase activity is increased in the hippocampus after multiple status epilepticus induced by pilocarpine in developing rats. Brain Res, 2007; 1138: 203-207.
27. Ruth RE: Kainic acid lesions of the hipocampus produced iontophoretically: the problem of distant damage. Expl Neurol, 1981; 76: 508-527.
28. +-ATPase) density in dementia as evaluated in fresh human cortical biopsies. Brain Res Cogn Brain Res, 1996; 4: 281-287.
29. Shiraishi K: A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure. Neurol Res, 1997; 19: 545-550.
30. Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O: Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res, 1985; 338: 289-295.
31. Sperk G, Wieser R, Widmann R, Singer EA: Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience, 1986; 17: 1117-1126.
32. Sperk G: Kainic acid seizures in the rat. Prog Neurobiol 1994; 42: 1-32.
33. +)-ATPase: function, structure, and conformations. Ann Neurol, 1984; 16(Suppl): 121-127.
34. +-ATPase: structure, function, and interactions with drugs. Adv Neurol, 1986; 44: 681-693.
35. +-activated p-nitrophenylphosphatase activities: a comparison of their regional localisations in the C57 mouse brain. J Neurochem, 1974; 23: 895-897.
36. + channels as targets for neuroprotective drugs. Trends Pharmacol Sci, 1995; 16: 309-316.
37. Waniewski RA, McFarland D: Intrahippocampal kainic acid reduces glutamine synthetase. Neuroscience, 1990; 34(2): 305-310.
38. Wasterlain CG, Fuijikawa D, Penix L, Sankar R: Pathophysiologieal mechanisms of brain damage from status epilepticus. Epilepsia, 1993; 34 (Suppl 1): 37-53.
39. Weiser T: A novel toxicity-based assay for the identification of modulators of voltage-gated Na+ channels. J Neurosci Methods, 2004; 137: 79-85.